MoonLake Immunotherapeutics: Form SC 13D, filed Apr 18, 2022
Filed with the SEC on Apr 18, 2022 and accepted by EDGAR at Apr 18, 2022, 16:49 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000921895-22-001288. Last ingested by Listed: Nov 4, 2026, 07:34 ET. Listed shows no prices and gives no investment advice.